FDA approves a nasal anti-histamine for non-prescription use


17 June 2021 - The U.S. FDA today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch. 

The FDA approved Astepro (azelastine hydrochloride 0.15% nasal spray) for seasonal and perennial allergic rhinitis—commonly known as allergies—for adults and children six years of age and older.

Read FDA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US , Over the counter